Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Siegfried Confirms the Forecasts After the First Semester

Summary by Moneycab
After the first half of the year, the pharmaceutical supplier Siegfried maintains its forecasts for the financial year 2026. Thanks to acquisitions, Zofinger will increase mainly in the second half of the year.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

After the first half of the year, the pharmaceutical supplier Siegfried maintains its forecasts for the financial year 2026. Thanks to acquisitions, Zofinger will increase mainly in the second half of the year.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Moneycab broke the news on Friday, August 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal